Cover Image

Drug–Drug Interactions and Combination Therapy Strategies of Amiodarone With Digoxin, Rivaroxaban, and Phenytoin Assessed by Physiologically Based Pharmacokinetic Modeling

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Youjun Chen, Zhiwei Liu, Yiming Li, Wenhui Wang, Tao Chen, Saiya Li, Yating Wu, Haitang Xie
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Association of Omeprazole‐Related Myopathy With Drug–Drug and Drug–Gene Interactions Involving CYP2C19 and CYP3A4: A Nested Case–Control Study
by: Eugene Jeong, et al.
Published: (2025)

Development and Validation of a Time‐Dependent Nomogram for Predicting Hematological Toxicity Risk During Linezolid Therapy in Drug‐Resistant Tuberculosis
by: Wenqiang Zhou, et al.
Published: (2026)

Harnessing the Power of Artificial Intelligence to Enhance Drug Therapy Research
by: William L. Baker, et al.
Published: (2026)

Probiotic Supplementation as an Adjuvant Therapy in Pediatric Drug‐Resistant Epilepsy: A Double‐Blind Placebo‐Controlled Trial
by: Amira R. Rashdan, et al.
Published: (2026)

Thrombosis Across Female‐Specific Malignancies: From Chemotherapy‐Driven Risk to Prophylaxis and Drug Interactions
by: Maryam Aghakouchakzadeh, et al.
Published: (2026)

Bayesian Dosing Simulator ( BDS ): A Pharmacokinetic Modeling Tool for Optimized Antibiotic Therapy
by: Adrian Valadez, et al.
Published: (2026)

Pharmaceutical Considerations for Oncology Risk, Screening, and Drug Dosing in the Transgender Population
by: Amy Broadwater, et al.
Published: (2026)

Identifying Pediatric Drug Safety Knowledge Gaps: An Integrated Approach Leveraging Real‐World Data, a Biomedical Knowledge Base, and Postmarketing Surveillance Data
by: Saurabh Rahurkar, et al.
Published: (2025)

Kidney Damage Biomarkers: A Missing Piece of the Diagnostic and Management Puzzle for Acute Drug‐Related Kidney Diseases
by: Sandra L. Kane‐Gill
Published: (2025)

Correlation Between Analgesic and Sedative Drug Withdrawal and Salivary Cortisol Levels in Children in PICUs : A Prospective Cohort Study
by: Yaping Zhan, et al.
Published: (2025)

DILIConsult : A Multi‐Agent Large Language Model Framework for Evaluating Drug‐Induced Liver Injury in ICU Settings
by: Alfred Zheng Ting Ho, et al.
Published: (2026)

Developing a Statistical Modeling‐Based Machine Learning Approach for Capturing Drug Dosing Using a Proton Pump Inhibitor Case
by: Amanda Massmann, et al.
Published: (2025)

Antiviral influenza treatments and hemorrhage‐related adverse events in the United States Food and Drug Administration Adverse Event Reporting System (FAERS) database
by: Jyotirmoy Sarker, et al.
Published: (2024)

Pharmacokinetic Analysis of Intravenous Push Cefepime in Critically Ill Patients With Sepsis
by: Susan E. Smith, et al.
Published: (2026)

Pharmacokinetics of Ceftolozane/Tazobactam in Patients With Partial‐ and Full‐Thickness Skin Burns
by: Ronald G. Hall, et al.
Published: (2025)

Association of Human Leucocyte Antigen with Tacrolimus Pharmacokinetics in Renal Transplant Patients
by: Rashmi J. Hemani, et al.
Published: (2026)

Correction to “Pharmacokinetics of Ceftolozane/Tazobactam in Patients With Partial‐and Full‐Thickness Skin Burns”
Published: (2025)

Correction to “Relationship of the Revised Anticholinergic Drug Scale With Cultured Cell‐Based Serum Anticholinergic Activity and Cognitive Measures in Older Adults With Mild Cognitive Impairment or Remitted Depression”
Published: (2025)

Pharmacokinetic and Pharmacodynamic Principles and Concepts Remain Relevant in the Era of Artificial Intelligence and Machine Learning
by: Keith A. Rodvold
Published: (2026)

Impact of Dosing Interval Adherence on Pharmacokinetic Outcomes of Recombinant Erwinia Asparaginase in Pediatric Leukemia or Lymphoma
by: Milre M. Matherne, et al.
Published: (2026)

Pharmacokinetics of continuous infusion ceftolozane/tazobactam in two patients with extensive total body surface area burns
by: Jay D. Olivet, et al.
Published: (2025)

Development and Validation of a Novel Scoring Model Integrating Clinical Risk Factors and Pharmacokinetic Parameters to Predict Vancomycin‐Induced Nephrotoxicity
by: Yoshihiko Matsuki, et al.
Published: (2026)

Pharmacokinetics of Sulbactam/Durlobactam in a Patient With Acute Renal Failure, Severe Obesity, and Carbapenem‐Resistant Acinetobacter baumannii Bacteremia: A Case Report
by: Dan Ilges, et al.
Published: (2025)

Pharmacokinetic and pharmacodynamic evaluation of sulbactam‐durlobactam in a critically ill patient on continuous venovenous hemofiltration infected with carbapenem‐resistant Acinetobacter baumannii‐calcoaceticus complex
by: Wesley D. Kufel, et al.
Published: (2025)

Current and Emerging Pharmacologic Therapies for Diabetic Retinopathy
by: Jennifer N. Clements, et al.
Published: (2026)

Cancer Therapy‐Induced Cardiotoxicity: A Narrative Review
by: Drew A. Wells, et al.
Published: (2026)

A Multicenter, Open‐Label Study to Assess the Safety of Nebulized Tissue Plasminogen Activator for the Acute Treatment of Pediatric Plastic Bronchitis: The PLATyPuS Trial
by: Kathleen A. Stringer, et al.
Published: (2025)

Constructing a Personalized Treatment Rule for Initial Therapy in Early Parkinson's Disease
by: Zachary P. Brehm, et al.
Published: (2025)

Predictors and Clinical Outcomes of Long‐Term Opioid Therapy in Older Adults: A Systematic Review
by: Iftekhar Ahmed, et al.
Published: (2026)

Biological Therapy and Small Molecules for Adults With Crohn's Disease: Systematic Review and Network Meta‐Analysis
by: Daniela Gorski, et al.
Published: (2025)

Machine Learning‐Based Prediction of Prolonged Duration of Mechanical Ventilation Using Medication Data
by: Brian Murray, et al.
Published: (2026)

Combination eravacycline therapy for ventilator‐associated pneumonia due to carbapenem‐resistant Acinetobacter baumannii in patients with COVID‐19: A case series
by: Melissa N. W. Jackson, et al.
Published: (2024)

Precision Daptomycin Dosing: Comparison of 3‐, 2‐, 1‐, and 0‐Concentration Sample Strategies
by: Simone Giuliano, et al.
Published: (2025)

Effect of proton pump inhibitors versus histamine‐2 receptor antagonists on acute kidney injury in septic patients at high risk for developing stress ulcers
by: Hua‐Ping Fan, et al.
Published: (2024)

Beyond Monotherapy: The Superior Efficacy of Combined GLP ‐1 Receptor Agonist and SGLT2 Inhibitors on Renal Biomarkers: A Systematic Review and Meta‐Analysis
by: Aya M. AbdelMagid, et al.
Published: (2026)

Belzutifan's role in the treatment landscape of clear cell renal cell carcinoma
by: Adrienne H. Chen, et al.
Published: (2025)

Association of Pneumonia, Fracture, Metabolic, and Renal Events With Long‐Term Proton Pump Inhibitor Use in Patients With Chronic Kidney Disease
by: Yi‐Fan Chien, et al.
Published: (2025)

Treatment Adherence to Oral Direct‐Acting Antiviral Agents in Hepatitis C Infection
by: Javeria Khalid, et al.
Published: (2026)

Optimal starting dosing regimen of intravenous oxytocin for labor induction based on the population kinetic‐pharmacodynamic model of uterine contraction frequency
by: Zhiheng Yu, et al.
Published: (2024)

Utilizing Machine Learning to Identify Predictors of Corticosteroid Discontinuation 1‐Year After Adult Heart Transplant
by: Caroline Chen, et al.
Published: (2025)